ESPE Abstracts (2024) 98 P2-297

ESPE2024 Poster Category 2 Late Breaking (107 abstracts)

CYP21A2 genotype and phenotypic manifestation in children with congenital adrenal hyperplasia from a tertiary care center in Eastern India.

Sukla Samaddar 1 , Subrata Dey 1 , Neethu Raj 1 & Alec Correa 2


1Apollo Multispecialty Hospital, Kolkata, India. 2Apollo Proton Cancer Center, Chennai, India


Introduction: Genetic mutation in the CYP21A2 gene presents with various phenotypes in congenital adrenal hyperplasia (CAH). We conducted a cross-sectional study of the genotypic pattern and its corresponding phenotype at a tertiary care hospital of Eastern India.

Method: We screened all children aged between 0-18 years under follow-up who underwent genetic analysis for CYP21A2 mutations based on clinical or biochemical features of classic or non-classic CAH. Phenotypic findings, MLPA and Sangers sequencing reports were noted.

Results: A total of 24 variants were detected in 14 subjects. The most common genetic mutations noticed were c.293-13 A/C>G in intron 2, c.-113G>A (113bp SNP) in the promoter region and c.332_339delGAGACTAC (8 bp del) (p.Gly111Valfs) in children with salt wasting phenotype. While c.518T>A (p.lle173Asn in exon 4 and c.1069C>T (p.Arg357Trp) in exon 8 was seen in those with simple virilizing phenotype. Although, reported more commonly, only 1 child had a large deletion in CYP21A2 who presented in severe salt wasting and complete virilization in a genetic female.

Table 1: Genotypic variant in CYP21A2 and phenotypic correlation:
Subject: Variant 1 Variant 2 Variant 3 Phenotype
1 Intron 2
c.293-13 A/C>G (I2G)
Heterozygous duplication of Exon 7 (VUS) - SW
2 Intron 2
c.293-13 A/C>G (I2G)
- - SW
3 Intron 2
c.293-13 A/C>G (I2G)
Promoter region
c.-113G>A
(113bp SNP)
- SW
4 Intron 2
c.293-13 A/C>G (I2G)
Promoter region
c.-113G>A
(113bp SNP)
Exon 3
c.332_339delGAGACTAC (8 bp del)
(p.Gly111Valfs)
CSW
5 Exon 4
c.518T>A
(p.lle173Asn)
Exon 8
c.1069C>T
(p.Arg357Trp)
- SV
6 Exon 4
c.518T>A
(p.lle173Asn)
5’UTR to Exon 6 deletion - SV
7. Exon 4
c.518T>A
(p.lle173Asn)
Exon 3 promoter region deletion - SV
8 Promoter region
c.-113G>A
(113bp SNP)
- - SW
9 Promoter region
c.-113G>A
(113bp SNP)
Exon 3
c.332_339delGAGACTAC
(p.Gly111Valfs)
- SW
10 Exon 8
c.1069C>T
(p.Arg357Trp)
Exon 4
Large deletion/ gene conversion
CYP21A2-CYP21A1P
- SV
11 Exon 7
c.923dupT
(p.Leu308PhefsTer6)
- - SW
12 5’UTR
c.-4C>C/T
(VUS)
- - SW
13 Promoter region to Exon 7 large contiguous heterozygous deletion Exon 8
c.1092delG
(p.L364PhefsTer80)
- SW
14 c.(447+1_448-1)_(549+1_550-1)conNR_040090.1:N.(877+1_878-1)_(979+1_980-1)
CYP21A2-CYP21A1P gene conversion
- - SW
SW – salt wasting, SV- simple virilizing

Conclusion: 5 pathogenic variants were seen in more than 1 children in our cohort. There was no overlap in genotype between the salt wasting and simple virilizing types. The genetic information is pivotal in mapping the genetic pool of this region with consistent phenotypic correlation.

Volume 98

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.